KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 78 filers reported holding KEZAR LIFE SCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,814 | -51.1% | 53,625 | +0.8% | 0.00% | 0.0% |
| Q2 2023 | $130,396 | -7.7% | 53,223 | +17.9% | 0.00% | 0.0% |
| Q1 2023 | $141,254 | -56.7% | 45,129 | -2.6% | 0.00% | -66.7% |
| Q4 2022 | $326,318 | +1.3% | 46,352 | +24.1% | 0.00% | 0.0% |
| Q3 2022 | $322,000 | +8.8% | 37,365 | +4.3% | 0.00% | 0.0% |
| Q2 2022 | $296,000 | -64.7% | 35,837 | -29.0% | 0.00% | -66.7% |
| Q1 2022 | $839,000 | -11.8% | 50,508 | -11.2% | 0.01% | -18.2% |
| Q4 2021 | $951,000 | +86.5% | 56,875 | -3.7% | 0.01% | +120.0% |
| Q3 2021 | $510,000 | +48.3% | 59,070 | -6.7% | 0.01% | +66.7% |
| Q2 2021 | $344,000 | -31.1% | 63,340 | -24.3% | 0.00% | -40.0% |
| Q1 2021 | $499,000 | +15.5% | 83,707 | +1.1% | 0.01% | 0.0% |
| Q4 2020 | $432,000 | – | 82,820 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
| Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
| Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
| Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
| CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
| Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
| Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |